International Conference on
Infectious Diseases and Clinical Microbiology
- September 23-25, 2019
- London, UK
Dr. Guirakhoo is CSO at GeoVax and was named one of the ‘50 Most Influential People in Vaccines’ in Vaccine Nation’s 2014 list. His previous assignments were CTO at Vaxess, CSO at Hookipa Biotech and Executive Director of External R&D at Sanofi Pasteur. He co-invented the ChimeriVax™ technology platform in association with St. Louis University which resulted in commercial products for dengue, JE and WN. Dr. Guirakhoo holds a BSc in Biology, a MSc in genetics, and a PhD in Virology. Dr. Guirakhoo has filed for more than 200 patents, 20 issued and published 90 papers in peer reviewed scientific journals including 13 book chapters.